Expert Interview: Dr. Francisco Contreras

Could antiparasitic drugs have a role in cancer care? James Templeton sits down with Dr. Francisco Contreras, a surgical oncologist with more than four decades of experience and president and medical director of Oasis of Hope Cancer Center in Tijuana, Mexico. Educated in Mexico and trained in surgical oncology at the University of Vienna, Dr. Contreras brings a perspective shaped by conventional medicine, integrative therapies, and a commitment to caring for the whole person.

In this wide-ranging conversation, Dr. Contreras shares his views on ivermectin, fenbendazole, and mebendazole as potential cancer therapies. He also explains why he believes chemotherapy’s role could change dramatically over the next 10–20 years, while discussing when chemotherapy and immunotherapy drugs such as Keytruda can be beneficial.

Viewers will also hear about therapies used at Oasis of Hope, including hyperbaric oxygen, ozone, laetrile, and targeted treatments; why biological dental examinations are part of the clinic’s evaluation; and what patients can expect during a recommended three-week stay.